论文部分内容阅读
矽肺是严重威胁矽尘作业工人健康和生命的一种职业病。我国对矽肺防治药物的研究一直比较重视,并取得了一定的成绩。本文拟结合近几年国内外在抗矽肺药物研究中取得的某些新进展,作一简要介绍。研究近况一、高聚物1.克矽平(P_(204),poly-2-vinylpyridine-N-oxide):本品为聚-2-乙烯吡啶氮氧化物,分子量约10万。1964年国内首先由天津医药工业研究所合成,1967年我国首次试用于临床,并于1970年进行鉴定。它是我国研究最早、近期
Silicosis is a serious occupational disease that threatens the health and life of silica dust workers. Our study on the prevention and treatment of silicosis has been paying more attention and some achievements have been made. This article intends to combine the recent years at home and abroad in the anti-silicosis drugs made some new progress made a brief introduction. Recent developments First, the polymer 1. Ke Si Ping (P_ (204), poly-2-vinylpyridine-N-oxide): This product is poly-2-vinyl pyridine nitrogen oxides, molecular weight of about 100,000. In 1964, the first domestic synthesis by the Tianjin Institute of Pharmaceutical Industry, China’s first trial in 1967 in clinical trials, and in 1970 identified. It is the earliest and recent study in our country